Frataxin deficiency unveils cell-context dependent actions of insulin-like growth factor I on neurons
<p>Abstract</p> <p>Background</p> <p>Friedreich’s ataxia (FRDA) is a neurodegenerative disease caused by deficiency of the mitochondrial iron chaperone frataxin (Fxn). FRDA has no cure, but disease-modifying strategies to increase frataxin are under study. Because insul...
Main Authors: | Franco Carolina, Fernández Silvia, Torres-Alemán Ignacio |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-10-01
|
Series: | Molecular Neurodegeneration |
Subjects: | |
Online Access: | http://www.molecularneurodegeneration.com/content/7/1/51 |
Similar Items
-
Liver Growth Factor (LGF) Upregulates Frataxin Protein Expression and Reduces Oxidative Stress in Friedreich’s Ataxia Transgenic Mice
by: Lucía Calatrava-Ferreras, et al.
Published: (2016-12-01) -
Frataxin (FXN) Based Regulation of the Iron-Sulfur Cluster Assembly Complex
by: Rabb, Jennifer
Published: (2012) -
Adding a temporal dimension to the study of Friedreich's ataxia: the effect of frataxin overexpression in a human cell model
by: Tommaso Vannocci, et al.
Published: (2018-06-01) -
Highly specific ubiquitin-competing molecules effectively promote frataxin accumulation and partially rescue the aconitase defect in Friedreich ataxia cells
by: Alessandra Rufini, et al.
Published: (2015-03-01) -
Gene expression profiling in frataxin deficient mice: Microarray evidence for significant expression changes without detectable neurodegeneration
by: Giovanni Coppola, et al.
Published: (2006-05-01)